Introduction
Continuous exposure of cells to exogenous and endogenous DNA damage is implicated in the pathogenesis of various cancers. A host of complex cellular DNA repair mechanisms have evolved to counteract the deleterious eects of DNA damage in humans (Sancar, 1995) . In addition to the existence of several detoxi®cation systems, delay at speci®c stages of the cell cycle occur after DNA damage, most likely for the ecient and optimal removal of DNA lesions from the cellular genome before cell division (Grana and Reddy, 1995; Canman et al., 1994; Guengerich, 1988; Kastan et al., 1991) . It is suggested that the programmed death of cells may be yet another mode necessary for the elimination of potential precursor cells escaping DNA repair Homan and Liebermann, 1994) . Recent reports have demonstrated that the p53 tumor suppressor protein plays an integral role in such cellular response pathways to DNA damage (Nelson and Kastan et al., 1991 Kastan et al., , 1992 . The rapid accumulation of transcriptionally active p53 tumor suppressor protein upon genotoxic damage has been shown to be essential for G 1 -S cell cycle arrest. This occurs via the induction of p21, a potent inhibitor of cyclin dependent kinases regulating the cell cycle Dulic et al., 1994; Nelson and Kastan, 1994; Kastan et al., 1991 Kastan et al., , 1992 . While p53 is shown to play a de®nite role in triggering apoptosis following DNA damage (Kastan et al., 1992; Smith et al., 1994; El-Deiry et al., 1994; Price and Park, 1994; Lowe et al., 1993) , cells de®cient in p53, have been shown to undergo apoptotic cell death indicating the presence of other p53 independent pathways (Nelson and Venkatachalam et al., 1993) . Besides this function, p53 can act as a transcriptional activator of repair related genes like gadd45 and very recent studies have implicated a direct role of p53 in the excision repair process (Ford and Hanawalt, 1995) . Thus, the intracellular accumulation of p53 after DNA damage mediates a wide range of interrelated processes that ensure the faithful propagation of parental genomic sequences and the avoidance of mutations. In concordance with its pivotal role in guarding the genome, the p53 gene has been reported to be mutated in a majority of human cancers (Hollstein et al., 1991; Greenblatt et al., 1994) .
The increase in p53 levels following DNA damage of cells has been shown to result from an increase in halflife of the protein (Liu and Pelling, 1995; Abrahams et al., 1995) . While the biochemical and molecular modulators responsible for the stabilization of cellular p53 are yet to be discerned, some studies suggest that excision repair coupled formation of transitory DNA strand breaks is an important initial factor in the DNA damage response pathway (Nelson and Kastan, 1994) . Furthermore, DNA strand breaks that induce p53 protein levels also are known to activate various damage dependent cellular enzymes like poly(ADPribose) polymerase and DNA dependent protein kinases (Nelson and Kastan, 1994; Carson et al., 1986; Stierum et al., 1994; Anderson, 1993) . Indirect evidence from recent studies indicates that posttranslational protein modi®cations, namely poly ADP-ribosylation and phosphorylation may be involved in the increased half-life of the p53 protein (Whitacre et al., 1995; Khanna and Lavin, 1993) .
Benzo(a)pyrene is a major environmental pollutant present in automobile exhaust, cigarette smoke, various foods and industrial wastes (Phillips, 1983) . The diol-epoxide metabolite, (+)-anti-BPDE reacts at several nucleophilic sites in DNA and the covalent N 2 -dG-anti-BPDE adduct comprises more than 80% of the total adduct population (Osborne et al., 1981) . The DNA base alterations arising from exposure to (+)-anti-BPDE have been implicated in mutagenesis, carcinogenesis and cellular transformation (Harris, 1991; Conney, 1982) . In the present report we have used (+)-anti-BPDE as a model DNA damaging agent to study the modulation of the p53 induction response by inhibitors of poly(ADP-ribose) polymerase and PKC. The results indicate that the down regulation of PKC activity leads to an abrogation of p53 protein elevation following exposure to (+)-anti-BPDE. Inhibition of poly(ADP-ribose) polymerase activity by 3-aminobenzamide results in an attenuation of p53 accumulation in various cultured human cells exposed to carcinogenic (+)-anti-BPDE via, (a) a concomitant decrease in the absolute adduct levels upon pre-incubation of the cells with 3-AB and (b) a direct decrease in the protein accumulation upon postdamage incubation of the cells with the PARP inhibitor. The study also demonstrates that the formation of DNA stand breaks might not be the only necessary factor in the p53 accumulation response triggered by (+)-anti-BPDE. Lastly the data are presented to show that the downstream eects of DNA damage i.e. cell cycle arrest and apoptosis occur in a cell type dependent fashion.
Results
Dose dependence and time course of p53 accumulation after (+)-anti-BPDE treatment DNA damage serves as an important trigger to activate the cellular responses such as cell cycle arrest, DNA repair and apoptosis (Nelson and Kastan, 1994; Kastan et al., 1991) . To establish a dose-response relationship between (+)-anti-BPDE induced DNA damage and p53 induction, excision repair-pro®cient human ®broblast and lymphoblastoid cells were treated with increasing concentrations of the carcinogen (0.05 to 1.0 mM). The DNA damage levels as detected by non-competitive immuno-slot blot assays, for varying does used in these experiments, ranged from 3.76 to 107 adducts/10 6 nucleotides (Table 1) . To correlate the formation of DNA damage with p53 protein accumulation, whole cell extracts from treated and untreated control cells were analysed using antibodies speci®c for dierent epitopes of the tumor suppressor protein.
Results with low passage normal human diploid ®broblasts, showed a rapid and sustained accumulation of the p53 protein in response to (+)-anti-BPDE treatment. A brief treatment of the cells with the genotoxin resulted in a p53 induction response that was apparent with doses as low as 0.05 mM. Failure of p53 accumulation upon treatment of cells with the inactivated carcinogen (hydrolyzed in aqueous media) indicated that the response was due to the interaction of the reactive epoxide metabolite with the genome leading to DNA damage. The extent of p53 accumulation increased proportionally with the dose of the carcinogen. However the p53 induction response was saturable at all the time points from treatment with doses higher than 0.5 mM (Figure 1, top and center) . Time course experiments revealed that the tumor suppressor protein begins to accumulate as early as 2.5 h and remains at elevated levels for at least 24 h after exposure (Figure 1, center For subsequent studies to relate the eects of DNA damage on cell cycle arrest and apoptosis, lymphoblastoid cells grown in suspension cultures provided an useful cellular model. In order to establish that the p53 induction response was similar to that of ®broblasts, lymphoblastoid cells were evaluated under similar conditons. Genotoxin treated normal and repair de®cient (XPA) lymphoblastoid cells displayed an identical response in which the p53 protein levels were increased in a dose and time dependent manner (Figure 1 , bottom panel and data not shown).
Modulation of p53 accumulation by inhibition of poly(ADP-ribose) polymerase
It is now well documented that exposure to various physical and chemical carcinogenic DNA damaging agents cause an increase in poly(ADP-ribose) polymerase (PARP) activity within minutes of genotoxic insult (Whitacre et al., 1995) . The synthesis of poly(ADP-ribose) polymers has been described as a necessary accompaniment for ecient DNA repair processes (Satoh and Lindahl, 1992) . The periodic proximity and similarity of PARP activity induction and elevated p53 protein levels suggest that PARP may be a potential DNA damage inducible candidate involved in the post-translational modi®cation of the p53 protein conferring increased half-life (Whitacre et al., 1995) . To evaluate the importance of PARP for the p53 induction response, cells with normal PARP activity but dierent repair capacities were treated with the PARP speci®c inhibitor, 3-aminobenzamide (3-AB) before and after exposure of cells to (+)-anti-BPDE. As shown in Figure 2a (top), pre-incubation of normal lymphoblastoid cells with 3-AB led to a decrease in the overall induction of the p53 protein compared to cells treated with (+)-anti-BPDE alone. Densitometric quantitation of the ®lms, exposed to non-saturating densities, revealed a 50 ± 60% decrease in the intensity of the p53 protein bands at 4 and 8 h after DNA damage. The treatment of cells with 3-AB before carcinogen exposure also led to a concomitant decrease in the (+)-anti-BPDE-DNA adduct levels by *60% (Figure 2b ), indicating that the p53 accumulation was clearly a consequence of the induced DNA damage. However, the treatment of the cells with the PARP inhibitor, after genotoxic insult also resulted in a decreased p53 induction response ( Figure 2a ). Thus poly ADP-ribosylation itself may be directly involved in the pathway for the stabilization of the p53 protein.
Since poly(ADPR) synthesis in XPA cells has been shown to be defective due to the lowered amount of excision repair mediated strand breaks after DNA damage, repair-de®cient (XPA) lymphoblastoid cells were also treated under identical conditions (Berger et al., 1980; Berger and Sikorski, 1981 ). An analogous decrease in p53 levels was noticed in these cells when 3-AB was present prior to and after (+)-anti-BPDE treatment (Figure 2a, center) . In addition, preincubation of XP lymphoblastoid cells with 3-AB also resulted in a concurrent decrease in the (+)-anti-BPDE DNA adduct levels ( Figure 2b ). The decrease in p53 levels was not due to a reduced amount of protein loaded in the gel as indicated by the fast green dye (FG) staining of the lower portion of a representative protein blot at *35 Kd range (Figure 2a , bottom).
Induction of p53 levels by inhibitors of DNA replication
While various types of DNA lesions are shown to elevate the intracellular levels of p53, the initiating pathways responsible for this eect remain unclear. The role of DNA strand breaks in triggering p53 levels has been suggested but not proven unequivocally (Nelson and Hess et al., 1994) . To investigate the role of replication mediated DNA strand breaks at the polymerase pause sites due to (+)-anti-BPDE-DNA adducts, repair-de®cient lymphoblastoid cells were incubated with inhibitors of DNA replication immediately after exposure to the carcinogen at doses of 0.125 mM and 0.5 mM. Since these cells are de®cient in the excision repair pathway, DNA damage and the inhibition of replication would not lead to an increase in the formation of DNA strand breaks either through repair or replication (Nelson and . The results shown in Figure 3 describe the eect on p53 accumulation when the ribonucleotide reductase inhibitor, hydroxyurea and the DNA replication inhibitor, AraC were included in the post incubation period after carcinogen exposure. Densitometric evaluation showed that the presence of replication inhibitors in the culture medium following carcinogen exposure resulted in an enhancement (*2-fold) of the p53 protein accumulation when compared to cells treated with (+)-anti-BPDE alone, at 4 h ( Figure 3 , lanes 2 and 3 vs lanes 8 and 9) as well as 8 h (Figure 3 , lanes 5 and 6 vs lanes 11 and 12). Interestingly, in control untreated cells, block of replication with HU and AraC, stimulated a p53 accumulation response that was detectable in 4 and 8 h as opposed to vehicle treated cells not blocked for replication ( Figure 3 , lanes 1 and 7 vs lanes 4 and 10). This indicates that the perturbation of DNA synthesis might itself be a trigger for p53 induction. In separate experiments, treatment of cells with AraC alone caused an accumulation of p53 protein levels analogous to the response seen in combination with HU (data not shown).
Eect of Calphostin-C on DNA damage induced p53 levels
It has been recently suggested that the phosphorylation of the tumor suppressor protein might be necessary for its stabilization after DNA damage (Hupp and Lane, 1994) . To investigate the role of phosphorylation on p53 stabilization/induction, ®broblasts and lymphoblastoid cells were pre-treated for 1.5 h with 300 nM PKC inhibitor, calphostin-C and the induction patterns of the p53 protein were monitored subsequent to (+)-anti-BPDE treatment. Pre-treatment of both the ®broblast and lymphoblastoid cells with calphostin-C led to an abrogation of the elevated p53 response observable as a result of cellular DNA damage ( Figure  4 , top and center). This failure of p53 accumulation response by damage was observed at 4 and 8 h postincubation after carcinogen treatment. Once again the decrease in the amount of the p53 protein was not due to changes in the total amount of protein loaded as indicated by the fast green staining of the protein blots (Figure 4, bottom) . However, at the 8 h post treatment time, there was a slight increase in the levels of the p53 protein in the control cells treated with calphostin-C alone (Figure 4) . In parallel experiments, treatment of cells with a non-speci®c inhibitor of PKC, staurosporine (3 nM) did not appear to aect the DNA damage induced accumulation of p53 levels (data not shown).
Cell lineage dependent cellular response to DNA damage ± apoptosis vs cell cycle arrest
Earlier reports have shown that various eects and the subsequent fate of a cell in response to DNA damage, i.e., to undergo cell cycle arrest and/or apoptosis that occur is dependent on factors like cellular histotype, extent of genotoxic damage and funtional status of the relevant gene products i.e. p53 and bcl2 Di Leonardo et al., 1994; Lowe et al., 1993; Fan et al., 1994; Liebermann et al., 1995) . To delineate the dierences in the post-damage responses of distinct cellular histotypes, exponentially growing ®broblast and lymphoblastoid cells were treated with (+)-anti-BPDE and analysed for any apoptosis related internucleosomal DNA fragmentation. As shown in Figure  5a , agarose gel electrophoresis of cellular DNA from carcinogen treated lymphoblastoid cells showed a clear DNA breakdown but with fragments ranging in size from large high molecular weight to small oligonucleotides ( Figure 5a , lanes marked L-N). This type of degradation is associated with early stages of programmed cell death. Time course experiments revealed that the lymphoblastoid cells undergo cell cycle arrest before the induction of apoptosis at approximately 24 h (data not shown). In contrast, agarose gel analysis of DNA from ®broblasts did not indicate any detectable inter-nucleosomal DNA fragmentation or release of any high molecular weight DNA fragments (Figure 5a , lanes marked OSU-2). Morphological analysis of the lymphoblastoid cells also revealed cellular changes characteristic of apoptosis while the ®broblasts exhibited only an increase in cellular size resembling large senescent cells but no apoptosis associated changes (data not shown).
To substantiate the dierences in the above mentioned responses, cells were treated with the carcinogen and their transition through the cell cycle was analysed by¯ow cytometry at various posttreatment times. The mitotic inhibitor nocodazole (0.4 mg/ml) was added immediately to cultures after the genotoxin treatment to avoid confounding results due to cells escaping the G 2 /M phase (Bae et al., 1995) . It may be noted that, non-adherent ®broblasts were collected along with the trypsinized cells for the¯ow cytometric analysis. As shown in Figure 5b , normal ®broblasts and lymphoblastoid cells treated with ethanol vehicle alone showed a typical cell cycle pro®le of exponentially growing cultures with a higher fraction of the cells in the G 1 phase analysed at 24 h. Nocodazole treatment of these cells caused the expected shift and accumulation of control cells at the G 2 /M phase. However, treatment of ®broblasts to an initial dose of 1 mM of the carcinogen prevented the progression of cells from the G 1 phase and caused cell cycle arrest at the G 1 /S boundary. This response was clearly demonstrated from (+)-anti-BPDE treated cells that were prevented from escaping the G 2 /M phase by the presence of nocodazole in the cultures. About 82% of the original G 1 population was arrested at the G 1 phase in ®broblast cells treated with 1 mM of the carcinogen while the G 1 fraction had decreased to 25% in the control cells incubated with nocadazole. In contrast to ®broblasts, lymphoblastoid cells were able to activate programmed cell death observed at 24 h following carcinogen exposure (1.0 and 0.5 mM) and apoptotic cells appeared as a distinct population with a lower DNA content (Figure 5b) . Furthermore, analysis of ®broblasts treated with higher doses (up to 4 mM) of the carcinogen and isolated after longer post-treatment intervals (48 h) did not indicate any evidence of apoptosis (data not shown).
Discussion
Accumulation of cellular p53 protein in response to a variety of agents that damage DNA has been demonstrated in several earlier reports (Kastan et al., 1991; Hess et al., 1994; Bae et al., 1995; Bjelogrlic et al., 1994; Hall et al., 1993) . While the kinetics of the p53 induction response has been shown to be similar in repair-pro®cient and repair-de®cient cells, the biochemical and molecular events that lead to the increase in p53 levels have not been established clearly (Lu and Lane, 1993; Abrahams et al., 1995) . The enhanced p53 levels, due of stabilization of the protein, persists longer in repair-de®cient than repair-pro®cient cells (Abrahams et al., 1995) . Consistent with earlier studies, we observed an identical mode of p53 induction after DNA damage with repair-pro®cient and repairde®cient cells (Lu and Lane, 1993; Abrahams et al., 1995; Kaspin and Baird, 1996) . Our studies were aimed at elucidating the biochemical mediators responsible for the p53 damage response. However, in contrast to the reported ®ndings showing the requirement of DNA strand breaks for the p53 induction response in XP cells (Nelson and Kastan, 1994) , our data indicate that the increase in p53 levels may not be mediated solely via strand breaks. The induction and super-induction of p53 in XP lymphoblastoid cells treated with replication inhibitors in the absence and presence of (+)-anti-BPDE-DNA damage suggest that p53 elevation may result from any perturbation to the DNA replication machinery and/or stuctural distortions to the DNA helical structure. However, these results do not rule out the possibility of an increase in the amount of strand breaks at the sites of the stalled replication enzyme leading to an enhanced eect on p53 accumulation. Nonetheless, previous studies have shown that PARP is necessary for the ligation of DNA strand breaks (Chatterjee and Berger, 1994) . If DNA strand breaks are the only necessary trigger for the p53 elevation response, our experiments with the PARP inhibitor would have shown an increase in the above mentioned response in repair-pro®cient cells due to the lack of strand break ligation. These results, showing a decrease in the p53 accumulation response in the presence of the PARP inhibitor, argue against the role of DNA strand break formation as the only initiating factor in the p53 response pathway. Therefore, p53 might serve as a common cellular regulatory mediator for intracellular events speci®cally related to DNA replication that may potentially result in heritable genetic changes. This assumption is consistent with earlier ®ndings which have indicated that DNA replication inhibitors can induce cellular p53 levels (Khanna and Lavin, 1993; Hess et al., 1994) . Interestingly, the ability of p53 to bind structural distortions in DNA has recently been demonstrated (Lee et al., 1995) . Though these results were obtained in vitro, it is likely that p53 might be capable of binding gross structural distortions in the DNA as encountered with u.v. and bulky chemical lesions within the cell.
In spite of a plethora of published reports concerning the role of p53 in the DNA damage response pathway (Nelson and Kastan, 1994; Kastan et al., 1991 Kastan et al., , 1992 , the early steps in the signal transduction mechanism remain mostly hypothetical. Our data, with PARP and PKC inhibitors demonstrate that more than one pathway may be in place to ensure the elevation of p53 levels in response to DNA damage. The 50 ± 60% reduction in p53 levels in cell incubated in the presence of the PARP inhibitor 3-AB, indicate that poly(ADP-ribosylation) of p53 might be an important factor in stabilizing p53 levels. However, an earlier study has shown an enhancement of (+)-anti-BPDE induced cellular p53 levels by 3-aminobenzamide (Stierum et al., 1995) . The analytical methods and the dosage of the carcinogen (2.5 mM) used in these studies may be a reason for these contrasting eects. As shown in the results, the decrease in p53 protein was detectable only at lower exposure times of the immuno-blots that did not lead to saturating densities of the signal. Furthermore, poly ADP-ribosylation of the chromatin has been implicated in various nuclear processes like transcriptional regulation and DNA repair (Satoh and Lindahl, 1992; Lautier et al., 1993) . The reduced levels of carcinogen-DNA adduction in cells pre-incubated with 3-AB show that the dynamic nature of the chromatin can also modulate the extent of DNA damage caused by bulky carcinogens and is consistent with an earlier report (Kurian et al., 1992) . Nevertheless, the lowering of p53 levels upon postdamage incubation with 3-AB suggest that p53 is a potential candidate for modi®cation by poly ADPribosylation. The increased half-life of poly ADPribosylated p53 protein would provide an inequivocal proof for this assumption. Another explanation for the relative reduction in post-damage p53 levels may be the obstruction of the DNA binding capacity of the tumor suppressor protein due to the lack of poly ADPribosylation of histones. A recent report has documented the reduced p53 induction response in cells de®cient in PARP synthesis thus con®rming the potential role of poly ADP-ribosylation in this process (Whitacre et al., 1995) . Further studies are needed to address the role of PARP in stabilizing p53 levels.
Our results with the PKC inhibitor, calphostin-C appear to indicate that phosphorylation of p53 might be the primary mechanism by which the protein is stabilized in the nucleus following DNA damage. However, the ®nal conclusion about the role of protein kinase C in DNA damage induced signal transduction pathway(s) that lead(s) to p53 stabilization cannot be elucidated from the present data. Recent data also indicate that phosphorylation might be involved in the regulation of the post-damage p53 response and the ability of the tumor suppressor protein to bind its consensus sequences in the DNA (Zhang et al., 1994; Price and Calderwood, 1993) . Consistent with the role of p53 phosphorylation, the AT (ataxia-telangiectasia) gene product, a PI-3 kinase, has been suggested to be involved in the signal transduction pathway leading to the stabilization of p53 levels (Savitsky et al., 1995; Khanna et al., 1995; Khanna and Lavin, 1993) . This has been further substantiated by the abrogation of the sequence speci®c DNA binding capacity of p53 by a speci®c inhibitor of PI-3 kinase (Price and Youmell, 1996) . Our results are consistent with the report showing that calphostin-C can down-regulate p53 induction after gamma and u.v. irradiation in normal and ataxiatelangiectasia cells (Khanna and Lavin, 1993) . A direct role of PKC in regulating p53 function has been demonstrated by in vitro studies in which phosphorylation of the carboxy terminus of p53 leads to the activation of the DNA binding function of the protein (Hupp and Lane, 1994) . However, in spite of the evidence that p53 phosphorylation is involved in the DNA damage response, the sequence of events that link DNA damage and the down-stream stabilization of p53 remains unclear. Since the activity of kinases can in turn be regulated by phosphorylation, the role of PKC and PI-3 kinase in the p53 induction response may either be a direct one involving p53 phosphorylation, or an indirect one in which one of the proteins is regulated by the other. In addition, it is important to note that the observed decrease in p53 levels after calphostin-C treatment is not due to the decreased binding of antibodies to the unphosphorylated forms of p53 as the mixture of antibodies (clones 1801 and DO-7) used in this study do not discriminate between the phosphorylated and the unphosphorylated forms of p53 (Kumar and Spandau, 1995) . While the stabilization of p53 protein and its binding to consensus sequences (after DNA damage) might be mutually exclusive, earlier reports have indicated that the binding of p53 to its consensus sequences in the DNA leads to a change in the protein conformation that is similar to the mutant form (Halazonetis et al., 1993) and also confers resistance to ubiquitin mediated proteolysis (Molinari and Milner, 1995) . Thus, the inhibition of PKC activity might in turn perturb the ability of p53 to bind damaged DNA thereby increasing the degradation of the tumor suppressor protein which leads to a decrease in cellular p53 levels.
The cellular response to DNA damage is a complex phenomenon that is highly dependent upon various factors such as extent of damage, dierentiation status of the cell and cellular type. Indeed, our results show that cell cycle arrest and apoptosis occur in a cell type dependent fashion. The prolonged cell cycle arrest exhibited by ®broblasts even at higher doses indicate that these cells might be resistant to apoptotic cell death induced by DNA damage. This is in agreement with earlier reports that have shown that ®broblasts do not undergo apoptosis after DNA damage Di Leonardo et al., 1994) . While the lymphoblastoid cells and ®broblast cells appear to sustain a similar post-damage p53 induction response, the outcome of these events namely, cell cycle arrest and/or apoptosis seem to depend on cell type speci®c factors. It is of interest that the lymphoblastoid cells do not shown a typical oligo-nucleosomal DNA fragmentation as encountered with treatment of HL-60 cells (Venkatachalam et al., 1993) . The DNA fragmentation patterns suggest the presence of high molecular weight DNA fragments ranging from several kilobases to several hundred kilobases and are characteristic of early stages of programmed cell death (Walker et al., 1994) .
In summary, this study shows that DNA damage induced by the carcinogenic metabolite, (+)-anti-BPDE leads to a rapid and sustained increase in cellular p53 levels. The primary mode of p53 protein stabilization might occur via the phosphorylation of the tumor suppressor protein and poly(ADP-ribosylation) might serve as secondary means of regulation. In addition, the results demonstrate that DNA strand breaks are not the only necessary alterations responsible for the p53 elevation response. The immediate response of p53 protein stabilization accompanies the downstream processes of cell cycle arrest and/or apoptosis in a cell lineage dependent fashion.
Materials and methods

Cell culture and treatment
Normal human ®broblasts (OSU-2) were established in culture as described (Gibson-D'Ambrosio et al., 1986) and grown in DMEM supplemented with 10% fetal calf serum. Normal (GM02184C) and repair-de®cient (GM02250E, XPA) lymphoblastoid cells were obtained from the NIGMS Human Genetic Cell Repository (Camden, NJ) and grown in RPMI 1640 medium supplemented with 10% fetal calf serum and antibiotics at 378C in a humidi®ed atmosphere of 5% CO 2 . Exponentially growing cells were treated for 30 min with (+)-anti-BPDE (Midwest Research Institute, NCI Repository, Kansas City, MO) by the addition of 1/100 volume of freshly prepared carcinogen stock in 95% ethanol after replacing the growth medium with Hank's balanced salt solution. The monolayers of ®broblast cells were washed with PBS and maintained in fresh culture medium for varying post-treatment times. The lymphoblastoid cells, grown as suspension cultures were centrifuged and cell pellets were washed once with PBS before resuspending in fresh culture medium at a density of 0.3610 6 cell/ml. Cells were harvested at various posttreatment times, lysed by boiling for 10 min in sample buer (2% sodium dodecyl sulfate, 10% glycerol, 10 mM dithiothreitol in 62 mM Tris-HCl, pH 6.8, 10 mg/ml pepstatin and 10 mg/ml leupeptin), snap frozen in liquid nitrogen and stored at 7208C. For treatment with 3-aminobenzamide, cells were either pre-incubated for 1 h with 5 mM 3-AB before genotoxin exposure or mock treated with PBS. Both the pre-incubated and mock treated cells were further resuspended in fresh medium containing 5 mM 3-AB. In experiments with calphostin-C, cells were pre-incubated for 1.5 h with 300 nM of the PKC inhibitor before carcinogen treatment. Post-treatment times were calculated after removal of (+)-anti-BPDE by washing and zero time coincides with the start of continuous culturing in the presence of appropriate chemical modulator. All experiments were repeated at least twice and the results of representative experiments are shown in various ®gures.
Quantitation of DNA damage by immuno-slot blot assays
The (+)-anti-BPDE-DNA adduct levels were quantitated using non-competitive immuno-slot blot assays essentially as described (Venkatachalam et al., 1995) . Brie¯y, cells were lysed after treatment with the carcinogen for 30 min, treated with RNAase-A and proteinase K and subjected to multiple organic extractions. DNA concentration was estimated using the microdiphenylamine assay (Venkatachalam et al., 1993) . Various amounts of modi®ed and unmodi®ed single-stranded cellular DNA samples were blotted onto nitrocellulose membranes (Schleicher & Schuell, Keene, NH) under low vacuum in BRL Convertible device (Life Technologies, Gaithersburg, MD). The nitrocellulose membranes were baked at 808C for 1 h and blocked overnight at 378C with Blotto (20 mM Tris-HCl, pH 8.0, 120 mM glycine, 5% dry milk powder, 0.5% gelatin, 0.1% sodium azide, 0.01% antifoam-A and 0.1% Tween-20). The ®lters were then incubated with primary antibodies (BP1, rabbit polyclonal antibodies speci®c for (+)-anti-BPDE-DNA adducts) (Venkatachalam and Wani, 1994) followed by secondary antibodies (Goat anti-rabbit alkaline phosphatase conjugate, Boehringer Mannheim, Indianapolis, IN) for 1 h at 378C. The bound enzymatic activity was determined by color development with a substrate solution of 0.33 mg/ml nitro blue tetrazolium and 0.17 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (Sigma) in Tris-HCl buer (100 mM Tris, 100 mM NaCl, 5 mM MgCl 2 , pH 9.5). The adduct levels were calculated by comparing the band intensities of the samples with (+)-anti-BPDE modi®ed DNA standard samples run in parallel as described (Venkatachalam et al., 1995) .
Immunoblot analysis of p53 protein levels
Western blot analysis was performed with aliquots from a constant number of cells obtained from the estimation of DNA content in the cell lysates. For DNA content estimation, aliquots of the cell lysates were precipitated with 5% ice cold TCA in the presence of 0.5 mg tRNA and pelleted by centrifugation at 13 000 r.p.m. The precipitates were brie¯y rinsed with 70% ice-cold ethanol, resuspended in TE and processed by microdiphenylamine assay as described (Venkatachalam et al., 1993) . Protein extracts from equivalent number of cells (1.2610 5 cells i.e. 875 ng DNA from TCA precipitates) were separated in 8% SDSpolyacrylamide gels and transferred to nitrocellulose membranes by using a semi-dry electroblotter (Hoeer, San Francisco, CA). Equal protein loading was con®rmed from visualization of the membranes stained for 15 to 20 min with fast green (0.1% fast green, 5% glacial acetic acid and 20% methanol). For p53 protein detection, the nitrocellulose membranes were blocked with 5% milk powder in TBST buer (100 mM Tris, 150 mM NaCl, 0.05% Tween, pH 7.4) for 2 h and incubated overnight with a mixture of anti-p53 protein antibodies at 1 : 200 dilution (p53 Ab-2 and p53 Ab-6 from hybridoma clones 1801 and DO-1 respectively; Neomarkers, Freemont, CA) at room temperature. The membranes were further incubated with the secondary antibody reagent (goat antimouse horseradish peroxidase conjugate antibodies; Boehringer Mannheim, Indianapolis, IN) at 1 : 2000 dilution for 2 h at room temperature. Following each antibody incubation the membranes were thoroughly washed with TBST buer. The p53 protein bands were detected from the peroxidase activity using the enhanced chemiluminescence substrate reaction (Pierce, Rockford, IL) essentially according to the manufacturer's instructions using X-OMAT AR ®lm (Kodak, Rochester, NY).
Flow cytometric analysis of cells
Carcinogen treated and mock treated human cells in culture (1 ± 2610 6 ) were rinsed with phosphate buered saline, resuspended in fresh cell culture media containing 0.4 mg/ml nocodazole and incubated further for 24 h (Fan et al., 1994) . Cells were then collected, ®xed in ice-cold ethanol (70%), centrifuged at 1500 r.p.m. washed with PBS and resuspended in 0.8 ml PBS to give a ®nal concentration of 1 ± 2610 6 cells per ml. To the resulting single cell suspensions, RNase-A (0.1 ml of 0.1 mg/ml) and propidium iodide (0.1 ml of 0.4 mg/ml) were added and cells were incubated at 378C for 30 min. Cell cycle analysis was performed using a Coulter EPICS Elite cytometer (Hialeah, Fl) . At least 15 000 gated cells were analysed for each time point with Multicycle software (Phoenix Flow Systems, San Diego, CA) and the coecient of variance (CV) values were below 5%.
DNA fragmentation analysis
DNA fragmentation analysis was performed essentially as described (Sellins and Cohen, 1987) . Brie¯y, DNA from cells was isolated by cellular lysis and fragmented DNA was separated from native intact DNA by centrifugation. The 13 000 g supernatant was treated with RNAase-A for 30 min at 378C followed by Proteinase K for 1 h at 458C. Aliquots of DNA corresponding to *1610 6 cells were resolved by gel (0.8% agarose) electrophoresis and visualized by ethidium bromide staining.
